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Diabetes is now the biggest cause of amputation, stroke, blindness and end stage renal failure. It causes many
deaths from cardiovascular disease. Foot ulcers and amputations reduce the quality of life, increase mortality and
involve lengthy stay in hospital. Many people who have an ulcer eventually require surgery. The economic cost to
the nation is spiralling out of control with estimates of 10% of the entire NHS budget spent on diabetes. This paper
aims to explore the burden of diabetic complications and how policy, guidelines and audit highlight the
discrepancies in the quality of diabetes care with particular reference to diabetes foot services. The findings suggest
that the NICE guidelines for diabetes foot care are not being adhered to and that the variation in preventative
amputations across England is unacceptable. Diabetes UK, the national charity for diabetes is leading a campaign to
improve diabetic foot care in light of the available published health information.Background
Diabetes is one of the most challenging health problems
in the 21st century [1]. The recent Association of Public
Health Observatories prevalence model suggests that
there are 3.1 million people with diabetes in England
and if this trend continues, the number will rise to an
estimated 4.6 million of the adult population by 2030
[2]. This increase in prevalence has significant economic
importance to say nothing of the associated burden of
associated mortality and morbidity [3]. The prevalence
of diabetes is approximately four times higher than all
cancers and continues to rise [4].
There are two primary forms of diabetes, Type 1, char-
acterised by the absence of insulin and Type 2 charac-
terised by insulin resistance. In the UK, approximately
10% have Type 1 and 90% have Type 2 [5]. Every year,
the condition is associated with 75,000 deaths, many of
which are preventable [6]. The associated tissue compli-
cations can be devastating, these include blindness, kid-
ney failure, cardiovascular and cerebrovascular disease
and amputation [5]. Approximately 6000 people with
diabetes have a leg,foot or toe amputation each year in
England and If current trends continue, the amputation
rate will increase from 6000 in 2009/10 to more than
7000 in 2014/15 [7].Correspondence: A.D.McInnes@brighton.ac.uk
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reproduction in any medium, provided the orThe cost of diabetes care to the NHS was almost £10
billion in 2011, which is 10% of the total NHS budget.
Most of the spending was on managing avoidable com-
plications, accounting for 80% of the total NHS diabetes
cost [8]. When indirect costs are added to the direct
costs described above for 2010/2011, the figure rises to
£23.7 billion with projected estimates for 2035/2036 of
£39.8 billion (direct plus indirect costs) [8]. Indirect
costs are estimated from mortality data, sickness data,
potential loss of productivity among people who remain
in work, and informal care [8]. All of the aforemen-
tioned data relates to the UK. However, for this paper,
the majority of data is based on England and Wales only,
unless otherwise stated.
One of the most costly consequences of diabetes in
England are significant hospital admissions, given that at
any one time around 15% of inpatients have been
recorded as having diabetes [9]. The length of stay tends
to be longer for those with diabetes with a recorded
4,892,000 nights spent in hospital during 2009-10 which
is 19.4% more than for patients without diabetes [9]. Life
expectancy is reduced for people with diabetes from 6 to
20 years [10] and deaths from diabetes in England are
high with 26,300 [between ages 20-79] in 2005 with an
anticipated increase as diabetes prevalence rates rise
[11]. In the UK, diabetes is the main cause of blindness
in people of working age [12,13], increased rates ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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contributor to cardiovascular disease [14].
The UK Government recognises the impact that dia-
betes has on the population and outlined a vision for
diabetes care in England in the National Service Frame-
work for Diabetes[NSF] published in 2001 [15]. The
Framework states twelve standards of care to be
achieved by 2013. However, there is still much to be
achieved despite some significant improvements across
the country [16]. With the increased prevalence in dia-
betes and other chronic conditions associated with an
unhealthy lifestyle, the Department of Health responded
with reforms to improve the health of the nation and
improve the quality of health care. The introduction of
the NHS Outcomes Framework 2012/13 sets out national
outcomes that the NHS should be aiming to achieve.
These include preventing people from dying prematurely
and enhancing quality of life for people with long term
conditions [17], which clearly includes those with dia-
betes. Other Department of Health policy documents
that influence diabetes care include the white paper
Equity and excellence: Liberating the NHS 2010 and the
Health and Social Care Bill 2011. One of the key organi-
sations that are funded by the Department of Health is
NHS Diabetes. This organisation has also supported the
development of the National Diabetes Information Ser-
vice which also includes the National Diabetes Audit.
This organisation is the catalyst to achieve the standards
set out in the Diabetes Framework and in the National
Outcomes Framework and they have developed specific
programmes to improve the quality of diabetes care
across England.
NHS Diabetes have several networks including a na-
tional footcare network. A key objective is to reduce the
rate of amputations by 50% over a period of five years
[18]. Working alongside NHS Diabetes is the National
Institute for Clinical Excellence [NICE]. NICE is funded
by the Department of Health and have a number of
functions including the provision of detailed evidenced
based guidelines and quality standards for all aspects of
diabetes care. In addition, NICE has helped to improve
the Quality and Outcomes Framework [QOF] in 2010/11,
by recommending new indicators to help improve the
care of patients with conditions such as diabetes, de-
mentia and mental health problems. The QOF frame-
work is a voluntary programme for GPs to provide
evidence of achievement that certain clinical and health
indicators have been achieved. This scheme also pro-
vides valuable data about diabetes care.
The NHS Health Check programme which was
announced in 2008 is a systematic programme for
people aged between 40-74 to assess people’s risk of
developing Type 2 Diabetes, heart disease, stroke and
kidney disease [19]. However in 2011 only half of thehealth checks have been offered [20]. Whilst the NSF
for Diabetes and other organisations including the
valuable NHS Diabetes have contributed significantly,
the recent publication of the State of the Nation 2012
England [20] highlights the alarming trend in the
increase of complications. From 2006 to 2010, retinop-
athy increased by 118%, stroke by 87%, kidney failure
by 56%, cardiac failure by 43%, angina by 33% and
amputations by 26% [20].
The picture regarding amputation varies significantly
across England. Recent data has shown that both major
and minor amputations in people with diabetes varies
tenfold across all of the Primary Care Trusts (PCT) in
England. Over a 3 year period to March 2010, there were
16,693 amputations in people with diabetes [21]. This
variation in amputation rate suggests that diabetes foot
care is inadequate in many parts of the country. How-
ever the overall amputation rate increase is considerably
less than for the other tissue complications previously
described.
This paper aims to consider the costs and impact of
the complications of diabetes, and whether there is
greater focus on any one complication. Diabetic foot dis-
ease has major consequences in terms of morbidity and
associated mortality and diabetes foot services may fall
short of Government expectations.Epidemiology, impact and costs of diabetes in the UK
Successive governments in the UK have attempted to
improve the NHS by a plethora of white papers from the
Department of Health and more recently through the
Health and Social Care Bill 2012. The bill has been
regarded as the most controversial to date, with some
political commentators suggesting that there is a “privat-
isation by stealth” agenda in order to decrease the spiral-
ling increase in costs of the NHS. Others suggest the Bill
offers greater patient choice and influence over service
provision. The current budget of the NHS is around
£106 billion of which almost £10 billion is spent on dia-
betes care [8].
It is timely to consider the comparative costs of dia-
betes and its complications, given that there is data now
available via the National Diabetes Information Service,
the National Diabetes Audit and many research publica-
tions and economic reports. Given the variation in am-
putation rate across England [21] and the estimated
annual expenditure (2010-11) on foot ulcers and ampu-
tation to be between £639,015,210 and £661,767,953, it
is important to explore the costs of providing foot care
and to identify examples where service improvements
have been made in both provision of care and cost sav-
ings. The prevalence rates of diabetes complications
from 2006-2010 are displayed in Table 1.
Table 1 Prevalence rates of diabetic complications
(2006-2010)
Retinopathy increased by 118%
Stroke increased by 87%
Kidney failure increased by 56%
Cardiac failure increased by 43%
Angina increased by 43%
Amputations increased by 26%
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There are 2.9 million people with diabetes in the UK
[22] and diabetes is responsible for more than one in ten
(11.6%) [23] deaths in England in the 20-79 years old
group and is the fifth most common cause of mortality
in the world [24]. Half of all deaths from diabetes are
due to cardiovascular disease and stroke [23]. Cardiovas-
cular disease accounts for 44% of fatalities in people with
Type 1 diabetes and 52% in Type 2 [14] and people with
Type 2 have a two-fold increased risk of stroke within
the first five years of diagnosis [25]. Kidney disease
accounts for 21% of deaths in Type 1 and 11% in Type 2
diabetes [14].
Diabetes is the leading cause of blindness in people of
working age in the UK [20] and there are 4,200 people
in England who are blind as a result of diabetic retinop-
athy. This number increases by 1,280 each year [26].
Diabetes carries an increased risk of a person undergo-
ing lower extremity amputation 23 times higher than of
a person without diabetes [21]. Key data from a report
from Holman et al. [21] identified 34,109 amputations
over a three year period in England, of which 16,693
(48.9%) were in people with diabetes. The amputation
rates in England for people with diabetes varies ten-fold
- both major (range 0.22-2.20 per 1000 person-years)
and minor (range 0.30-3.25 per 1000 person-years) [21].
Hospital impact of diabetic complications
Data from the National Diabetes Audit 2011 identified
that people with diabetes account for 19% of all hospital
inpatients at any one time [27]. The most common rea-
son for admission overall is foot disease, however for
Type 1 patients, ketoacidosis predominates. The length
of stay for inpatients with diabetes tends to be longer
than those without diabetes, with a median stay of 8
nights compared with 5 nights. This results in about
5,912,836 bed days per year [28].
Of the patients that had been admitted for the man-
agement of diabetes, the highest proportion (47%) were
admitted with active foot disease. See Table 2 for other
reasons for admission. Hospital Episode Statistics record
72,459 inpatient episodes for diabetes and foot ulcer or
amputation for 2010-11[28]. Diabetic patients may be
admitted to hospital for reasons other than for foot ulceror may develop a foot ulcer during their stay. An ana-
lysis by Kerr [2] in 2012 estimated that in 34,836 admis-
sions coded to non-foot- ulcer related Healthcare
Resource Group (HRG), there were 417,804 excess bed
days for patients with foot ulceration. An HRG is a
grouping of patient events that consume a known re-
source. This is based on the diagnosis and anticipated
intervention procedure. Excess bed days are calculated
based upon the expected number of days that a proced-
ure would normally take and the number that are actu-
ally used.
Cost of acute diabetes complications in the UK
The total cost of direct patient care in the UK in 2010/11
is estimated at £9.8bn which is approximately 10% of
the NHS budget [8]. The cost of complications with
those with either Type 1 or Type 2 is estimated at
£7.7bn [8]. Table 3 displays the estimated costs for dia-
betic complications observed by Hex and colleagues
[8]. From their health economics paper, they demon-
strate that foot ulcer and amputation costs for 2010/11
were the most expensive complication to treat in terms
of hospital costs, followed by kidney failure and other
renal costs. However it is evident that if all cardiovas-
cular events were considered in combination, they
would be the most expensive of all.
Best practice management of diabetes complications
The Department of Health set out standards of care for
diabetes in 2001 in the National Service Framework for
Diabetes and these standards have been reinforced by
NICE in 2011. The Department aims were to improve
health outcomes, raise the quality of diabetes services
and reduce variations between them [15]. In addition
the Department have improved the identification of
people with diabetes via the GP practice registers and
the Quality and Outcomes Framework (QOF). The QOF
allows for the development of clinical and health im-
provement indicators across a range of areas including
diabetes. NICE are instrumental in the development of
these indicators. It is difficult to identify precise spend-
ing on Diabetes in the NHS in England and the National
Audit Office estimated that at least £3.9 billion was
spent in 2010, approximately 4% of the entire NHS
budget. The Audit Office acknowledges that this could
be an underestimation [29].
Aims not achieved
The Department of Health facilitated the development
of a national clinical audit with the Healthcare Quality
Improvement Partnership and there is evidence that the
standards are not being achieved across the country. In
2009-10, only half of the people with diabetes received
all of the recommended care processes to reduce the risk
Table 2 Reasons for admission to hospital (National
Diabetes Inpatients Audit of 2011)
Active foot disease 47% (of 9% of diabetic patient admitted








*Important to note that 66.6% were admitted for other medical reasons and
24.4% for non-medical/surgical reasons.
*Total number of 11,866 inpatients with diabetes.
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in five people with diabetes are achieving treatment
standards that reduce the risk of developing diabetes
related complications [29]. There is a great variation
across the country, with the percentage of people with
diabetes receiving all nine recommended care processes
ranging from 6 per cent to 69 per cent between primary
care trusts [20]. In terms of achieving treatment stan-
dards, the alarming figures from the National Diabetes
Audit for the year 2009-10, demonstrated that 84% of
patients did not achieve desired standards for blood glu-
cose, blood pressure and cholesterol which clearly puts
them at risk of developing avoidable complications in
later life [29]. One of the nine basic care processes for
people with diabetes to be delivered on an annual basis
includes a foot examination. Evidence from the National
Diabetes Audit for 2010-11 identified that 84.4% of
people with diabetes received a foot examination which
is an improvement of +0.26% from the previous year
[29]. However, that suggests that 15.6% did not receive
an annual foot check and when consideration is given to
the large figures involved, suggests that percentage
equate to over 200,000 people. Given that diabetes foot
complications are a considerable cost to the NHS, the
annual foot care examination data is disappointing.
Potential cost savings
It is difficult to identify the spending on diabetes care in
NHS England. Spending on diabetes has increased from
£0.9 billion in 2006-07 to £1.3 billion in 2009-10. The
Audit Office recognise that this figure is probably anTable 3 Estimated costs for diabetic complications
(2010-2011)
Foot ulcers and amputations £985,600,282
Kidney failure £514,066,538
Ischaemic heart disease £509,656,332
Myocardial Infarction £603,069,221
Stroke £287,931,944underestimate as there is a lack of accurate cost data for
primary care and community services and that hospital
cost mechanisms can be rather opaque. The Audit office
has calculated that £170 million a year could be saved by
the NHS with improved management of diabetes care.
The estimated savings could come from reduced hospital
admissions and emergency readmissions, reduced insulin
errors in hospital and a reduction in late referrals to spe-
cialist foot teams. It has been considered that a reduc-
tion of 50 per cent late referrals could save £34 million a
year by a reduction in amputations [29].
Future funding of diabetes complication management
One of the initiatives from the Department of Health
was the development of a national screening programme
for diabetic retinopathy [29]. The programme aims were
to reduce the prevalence of blindness through early de-
tection and treatment of diabetic retinopathy. The
programme was supported by the DOH funding the pur-
chase of digital cameras and other equipment for retinal
screening. There were 91 programmes implemented be-
tween 2003-08. In 2010-11, 79 per cent of people with
diabetes had been screed for retinopathy [29].The
programme has not been fully assessed as there is a lack
of data on those screened who have required follow up
treatment or have been registered blind [29].
Primary Care Trust spending on diabetes complica-
tions falls under programme budgeting data as part of
their spending on 23 programmes of care. This data
should inform commissioning decisions about best prac-
tice spending on diabetes care. However, as previously
mentioned there is a lack of quality cost information for
primary care and community services where the major-
ity of diabetes care is provided. There is a wide variation
of recorded diabetes related spending between primary
and secondary care across primary care trusts.
NHS Diabetes
The development of NHS Diabetes and the appointment
of a national clinical director for diabetes have led to sig-
nificant improvements in diabetes services. The aim of
NHS Diabetes is to provide a link between diabetes
strategy and frontline improvements for patients [30].
The core of their work is to aid the implementation of
the National Outcomes Framework and NICE Quality
Standards for Diabetes. There are a number of spokes to
the hub of NHS Diabetes in the form of networks which
include paediatric, older people, inpatient, foot care,
pregnancy and insulin pump networks.
One of the main targets of the foot care network is to
reduce the amputation rate by 50% by 2018. Other goals
endorse the NICE Quality standards and objectives of
the National Outcomes Framework that relate to dia-
betes foot disease in terms of standards of service and
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ever is about to undergo a seismic change as a result of
the Health and Social Care Act 2012. It is beyond the
scope of this paper to capture all of the main aspects of
the Act, suffice to state that at the core of the Act is; a
focus on putting clinicians at the heart of commission-
ing, the facilitation of innovation, empowerment of
patients and the drive for improvement in public health.
This focus is captured in the National Outcomes Frame-
work 2011-12 which features five domains with aspir-
ational aims which include: (i) preventing people from
dying prematurely; (ii) enhancing quality of life for
people with long term conditions; (iii) helping people to
recover from episodes of ill health or following injury;
(iv) ensuring that people have a positive experience of
care and (v) treating and caring for people in a safe en-
vironment and protecting them from avoiding harm.
NICE quality standards featuring diabetes are referred to
in the first two domains described.
Discussion
The new organisational structure of the NHS will include
a National Commissioning Board, accountable to the Sec-
retary of State for Health, that will guide and support clin-
ical commissioning groups who directly commission
services for their populations [31]. There are numerous
documents that have been reviewed to inform this paper
and the complexities of funding mechanisms, commis-
sioning, costings, interpretation of national audits and
other diabetes information products including economic
analyses are most challenging to unravel. The fact remains
that diabetes foot disease accounts for more hospital bed
days that any other complication, impacts on the quality
of life, results in significant morbidity and subsequently
increased mortality [28], it has been described as a Cinder-
ella service and there is evidence to support such a claim.
However, conversely, there is a significant health spend on
diabetic foot disease. Expenditure on foot ulcers is around
0.6% to 0.7% of all NHS spending and approximately £1 in
every £150 the NHS in England spends each year is on
diabetic foot ulcers [32]. This equates to £324,761,157
spent in Primary, Community, Outpatients and Accident
and Emergency on diabetic foot ulcers and £256,698,817
spent on inpatients with foot ulcers and amputations [28].
It is evident from the National Service Framework for
Diabetes, the National Outcomes Framework, NHS Dia-
betes, Diabetes NHS strategy, NICE Quality Standards
for Diabetes and Diabetes UK 15 health care essentials,
that the Department of Health and the national charity,
Diabetes UK share goals and targets for diabetes care
and complications that do not single out any one com-
plication more than another. However it is evident from
the report on the management of adult services in the
NHS by the National Audit Office [29] that theimplementation of all of the quality standards that have
been set for diabetes care have not been met and fur-
thermore, there is a significant variation in the standards
of care across all of the primary care trusts in England.
Before identifying all of the reasons for failure to meet
the standards, it may be useful to consider the mechan-
isms of provider payment as this may be a contributing
factor to the discrepancies identified.
Payment by Results (PbR)
The Payment by Results is a tariff based system that is
used by commissioners to pay the providers of health-
care. There are nationally determined currencies and set
prices for the tariff. The unit of healthcare may be an
outpatient attendance, a stay in hospital or a year of care
for a long term condition. The currencies are in the
form of a health resource group which captures both a
diagnosis and subsequent intervention which are indi-
vidually coded accordingly. The healthcare resource
group also includes the timeframe, e.g. from hospital ad-
mission to discharge. An example of on HRG and mean
tariff in relation to diabetic foot disease is: HRG: Ampu-
tation without major complications with a mean tariff of
£9297 and an HRG: Amputation with major complica-
tions with a mean tariff of £14,960 [28].
Standard contract
A standard contract in the NHS is between the provider
and the commissioner which is legally binding and is
based on the payment by results and nationally agreed
tariffs. The Health and Social Care Bill will lead to some
changes to the standard contract for 2012/13. There is a
greater emphasis on the services being commissioned.
The contract will bring together the core services
namely acute hospital, ambulance, community and men-
tal health/learning disability services. The contract also
includes indicators for delivery of high quality services.
Service specifications can be in a number of different
formats including care pathways. This type of service
specification may be preferable for diabetes foot services.
Commissioning for quality and Innovation (CQIN)
All contracts are required to include the national incen-
tive payment framework scheme. The CQIN scheme
allows the provider to identify a service for ambitious
improvement and innovation to enhance the quality of
the service. Successful CQIN activity carries a financial
incentive to the provider organisation.
Quality and Outcomes Framework (QOF)
This framework has previously been described in this paper
and provides a financial incentive for general medical prac-
tices to achieve a series of targets. There are several
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for foot screening and risk assessment [33].
To attempt to unravel the complexities of funding and at-
tempt to identify priorities in diabetes care is a complex
process. The National Audit Office concluded that the var-
iations in diabetes care cannot be explained by need or
spending alone [28]. They may be as a result of differences
in local organisation and management of the service. The
Audit Office also identified that the NHS lacks clarity on
the most effective ways to deliver diabetes services and that
there is variation in patient education, diabetes training and
in the provision of diabetes specialist nurses [28].
Podiatry services
The availability of podiatry services for inpatients with dia-
betic foot problems is a major issue. The National Inpati-
ents Diabetes Audit (2011) included 212 hospitals and 136
Trust sites. The report considered the provision of Podia-
try to be poor with an average of 5.0 hours per week per
300 hospital beds spent on inpatient care. This is of par-
ticular concern considering that 11.6% of admissions have
a history of foot disease and foot disease accounting for
nearly half of the diabetes specific admissions. Further dis-
appointing data shows that there has been an increase
from 26.8% to 30.9% in the number of sites with no podia-
try provision.
Clearly, despite the intentions of all of the national guid-
ance on diabetes care, podiatry services and the poor
provision of the multidisciplinary foot care team has prob-
ably resulted in relatively high numbers of amputations.
The cost of diabetic foot care remains disproportionately
high therefore as a result of these costly interventions.
There is evidence from Marion Kerr’s report that the suc-
cessful implementation of a multidisciplinary foot care team
with podiatrists at the centre can lead to significant savings
(28). For example, a study in Southampton demonstrated
that a diabetic foot protection team working across primary
and secondary care could reduce lengths of stay for foot
ulcer admissions, as well as reducing major amputations
[34]. Over a three year period, the median length of stay for
foot ulcer admissions fell from 47 to 19 days. This resulted
in an estimated saving of £1.3 million. The savings accrued
from a reduction in major amputations.
Conclusion
The provision of NHS diabetic foot services in terms of
Foot Protection Teams and Multidisciplinary Foot Care
Teams is poor in England. The National Inpatient Audit
for 2011 demonstrated that 40.5% of the sites that were
audited did not have a multidisciplinary foot care team.
In many parts of the country there are no clear path-
ways for referral of increased-risk or high risk patients
to foot protection teams, or for rapid referral of
patients with new ulcers to MDTs. This is despite therecommendations from NICE. Quality standard 10
states that people with diabetes should be reviewed
regularly by a foot protection team and that those pre-
senting with an urgent foot problem should be seen
and treated within 24 hours by a MDT. This standard
clearly cannot be met by many hospital sites across
England and Wales. NHS Diabetes Foot Care Network
has appointed clinical and podiatry champions across
England to try and drive improvements in service. In
addition a joint campaign, ‘Putting Feet First’ run by Dia-
betes UK, NHS Diabetes and the Society of Chiropodists
and Podiatrists is attempting to achieve improvements in
diabetes foot services and reduce the unacceptably high
rate of preventable amputations. When consideration is
given to the cost efficiencies that have to be achieved by
the NHS and the increase in prevalence of diabetes,
improvements have to be made. It is time to put feet first.
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